HTRA1 protein inhibitors (Theia Biosciences)

N/A

Report date: 2025/03/20 16:01:29
NME

Base Information

Drug NameHTRA1 protein inhibitors (Theia Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine protease HTRA1 inhibitors
TargetsSerine protease HTRA1
Therapy Area/IndicationsWet age-related macular degenerationGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of California, Riverside
China Registration ClassN/A

Develop Information

Active CompaniesTheia Biosciences
Inactive CompaniesUniversity of California, Riverside
Active IndicationsWet age-related macular degenerationGeographic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A